Abstract:Background The basal ganglia are important structures for the release of dopamine in the limbic circuits of the midbrain, and the striatum and globus pallidus are the major nuclei of the basal ganglia, and the dysfunction of these regions has been the basis of many models that have attempted to explain the underlying mechanisms of schizophrenia symptoms. The purpose of this study was to investigate the changes in the volume of the striatum subregion and globus pallidus in three different stages of schizophrenia, and to analyze whether these volume changes were related to antipsychotic drugs and schizophrenia symptoms. Methods In this study, we investigated the volume of the striatum and globus pallidus in patients with schizophrenia at three different stages. The study included 57 patients with first-episode schizophrenia (FSZ), 51 patients with early-stage schizophrenia (ESZ), 86 patients with chronic schizophrenia (CSZ), and 191 healthy controls (HC), all of whom underwent structured magnetic resonance imaging (MRI) scans. Covariance analysis was performed using SPSS 26.0 was used for covariance analysis to determine whether there were significant differences in striatal subregion and globus pallidus volume between groups, and stratified analysis was used to further eliminate the effect of age on brain volume. Finally, the correlation analysis between the region of interest and the cumulative dose of antipsychotic drugs and psychotic symptoms was performed. Results The comparison between the different stages of the illness showed significant volume differences in the left caudate nucleus (lCAU) ( F = 2.665, adjusted p = 0.048), left putamen (lPUT) ( F = 12.749, adjusted p < 0.001), left pallidum (lPAL) ( F = 41.111, adjusted p < 0.001), and right pallidum (rPAL) ( F = 14.479, adjusted p < 0.001). Post-hoc analysis with corrections showed that the volume differences in the lCAU subregion disappeared. Further stratified analysis controlling for age showed that compared with the HC, the lPAL ( t = 4.347, p < 0.001) was initially significantly enlarged in the FSZ group, the lPUT ( t = 4.493, p < 0.001), rPUT ( t = 2.190, p = 0.031), lPAL ( t = 7.894, p < 0.001), and rPAL ( t = 4.983, p < 0.001) volumes were all significantly increased in the ESZ group, and the lPUT ( t = 3.314, p = 0.002), lPAL ( t = 6.334, p < 0.001), and rPAL ( t = 3.604, p < 0.001) subregion volumes were also significantly increased in the CSZ group. Correlation analysis showed that lPUT and bilateral globus pallidus were associated with cumulative dose of antipsychotics, but were not associated with clinical symptoms in each subregion. Conclusion The findings suggest that different subregions of the striatum and globus pallidus show significant volume differences at different stages of schizophrenia compared to HC. These volume differences may be strong radiographic evidence for schizophrenia. In addition, the lPAL was the only significantly different brain region observed in the FSZ group, suggesting that it may be a sensitive indicator of early brain structural changes in schizophrenia. Finally, our findings support the hypothesis that antipsychotic drugs have an effect on the volume of brain structures.

Lower density of calretinin‐immunopositive neurons in the putamen of subjects with schizophrenia

Evidence for Decreased Density of Calretinin-Immunopositive Neurons in the Caudate Nucleus in Patients With Schizophrenia

Decreased Regional Homogeneity and Increased Functional Connectivity of Default Network Correlated with Neurocognitive Deficits in Subjects with Genetic High-Risk for Schizophrenia: A Resting-State Fmri Study.

Striatum and globus pallidus structural abnormalities in schizophrenia: A retrospective study of the different stages of the disease

The primary motor cortex of schizophrenia patients show neuronal and subcellular impairments in the right hemisphere – postmortem study

Oligodendrocyte and Interneuron Density in Hippocampal Subfields in Schizophrenia and Association of Oligodendrocyte Number with Cognitive Deficits

Analysis of the caudate nucleus transcriptome in individuals with schizophrenia highlights effects of antipsychotics and new risk genes

Perineuronal net density in schizophrenia: A systematic review of postmortem brain studies

Aberrant activity at rest of the associative striatum in schizophrenia: Meta-analyses of the amplitude of low frequency fluctuations

Spontaneous brain activity and synaptic density in schizophrenia: a combined [11C]UCB-J PET and fMRI study

Dynamic Cerebral Reorganization in the Pathophysiology of Schizophrenia: a MRI-derived Cortical Thickness Study

Cognitive impairment in schizophrenia is associated with prefrontal–striatal functional hypoconnectivity and striatal dopaminergic abnormalities

Structural Covariance of Depth-Dependent Intracortical Myelination in the Human Brain and Its Application to Drug-Naive Schizophrenia: a T1w/T2w MRI Study

Striatal and peripheral dopaminergic alterations related to cognitive impairment in patients with schizophrenia

Increased interstitial white matter neuron density in the dorsolateral prefrontal cortex of people with schizophrenia.

Brain structural abnormalities of the associative striatum in adolescents and young adults at genetic high-risk of schizophrenia: Implications for illness endophenotypes

Decreased Prosaposin and Progranulin in the Cingulate Cortex Are Associated with Schizophrenia Pathophysiology

Reduction in neurons immunoreactive for parvalbumin, calretinin and calbindin in the anteroventral thalamic nuclei of individuals with Down syndrome

Scaling of smaller pyramidal neuron size and lower energy production in schizophrenia

Abnormal Resting-State Connectivity in a Substantia Nigra-Related Striato-Thalamo-Cortical Network in a Large Sample of First-Episode Drug-Naïve Patients With Schizophrenia

Human iN neuronal model of schizophrenia displays dysregulation of chromogranin B and related neuropeptide transmitter signatures